Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R; Thielecke; Abel; Bergemann. Costs of irritable bowel syndrome in the UK and US. PharmacoEconomics. 2006, 24 (1): 21–37. PMID 16445300. doi:10.2165/00019053-200624010-00002.
Moayyedi, P; Quigley, EM; Lacy, BE. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis.. The American journal of gastroenterology. September 2014, 109 (9): 1367–74. PMID 25070054. doi:10.1038/ajg.2014.195.
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R; Thielecke; Abel; Bergemann. Costs of irritable bowel syndrome in the UK and US. PharmacoEconomics. 2006, 24 (1): 21–37. PMID 16445300. doi:10.2165/00019053-200624010-00002.
Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004, 10 (4): 299–309. PMID 15298528.
Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016 Feb 19:S0016-5085(16)00223-7. doi: 10.1053/j.gastro.2016.02.032. PMID 27144617.
Moayyedi, P; Quigley, EM; Lacy, BE. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis.. The American journal of gastroenterology. September 2014, 109 (9): 1367–74. PMID 25070054. doi:10.1038/ajg.2014.195.